Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse
FDA statement on scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse
